Creo Medical Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	20.5	8.7	3	13.1	43.53	45.09
Short-Term Investments	-	-	15.5	-	-	-
Cash & Short-Term Investments	20.5	8.7	18.5	13.1	43.53	45.09
Cash Growth	109.18%	-52.97%	41.22%	-69.91%	-3.45%	-44.36%
Accounts Receivable	3.4	1.3	7.8	5	3.88	4.24
Other Receivables	2.9	2.4	2.8	5.2	4.88	3.1
Receivables	6.3	3.7	10.6	10.2	8.76	7.33
Inventory	3.2	2.7	8.1	9.3	8.5	6.81
Prepaid Expenses	-	0.4	0.7	1.1	0.37	0.23
Other Current Assets	1.7	40.9	-	-	-	-
Total Current Assets	31.7	56.4	37.9	33.7	61.17	59.47
Property, Plant & Equipment	3.6	5.9	9.1	9.7	8.6	3.38
Long-Term Investments	32.8	2.1	2.1	2.6	1.73	0.5
Goodwill	-	-	19.1	19.6	18.56	18.26
Other Intangible Assets	0.7	0.3	6.8	7.8	8.33	9.78
Long-Term Deferred Tax Assets	-	-	1.1	1.5	1.71	0.47
Long-Term Deferred Charges	-	0.2	0.3	0.2	0.36	0.49
Other Long-Term Assets	-	0.1	0.2	0.1	0.15	0.11
Total Assets	68.8	65	76.6	75.2	100.61	92.46
Accounts Payable	3.6	0.9	5.7	4.3	3.54	2.46
Accrued Expenses	-	2.9	-	4.1	5.18	4.19
Short-Term Debt	-	-	2	3.8	3.32	3.34
Current Portion of Long-Term Debt	2.3	2.2	0.5	1.2	1.39	1.85
Current Portion of Leases	-	0.2	0.6	0.6	0.67	0.62
Current Unearned Revenue	-	0.1	-	-	-	-
Other Current Liabilities	0.1	14.2	1.1	3.4	5.63	5.56
Total Current Liabilities	6	20.5	9.9	17.4	19.74	18.03
Long-Term Debt	1.9	1.9	4.4	4.9	3.79	5.16
Long-Term Leases	-	0.1	0.8	1.2	1.39	1.39
Long-Term Deferred Tax Liabilities	-	-	1.4	2	1.79	2
Other Long-Term Liabilities	-	0.1	0.3	0.4	0.59	3.09
Total Liabilities	7.9	22.6	16.8	25.9	27.29	29.66
Common Stock	0.4	0.4	0.4	0.2	0.18	0.16
Additional Paid-In Capital	191.9	192	180.9	149.5	149.45	115.26
Retained Earnings	-159.3	-173.1	-144.4	-122.7	-95.76	-71.17
Comprehensive Income & Other	27.9	23.1	22.9	22.3	19.45	18.55
Total Common Equity	60.9	42.4	59.8	49.3	73.32	62.81
Shareholders' Equity	60.9	42.4	59.8	49.3	73.32	62.81
Total Liabilities & Equity	68.8	65	76.6	75.2	100.61	92.46
Total Debt	4.2	4.4	8.3	11.7	10.56	12.36
Net Cash (Debt)	16.3	4.3	10.2	1.4	32.98	32.74
Net Cash Growth	-	-57.84%	628.57%	-95.75%	0.74%	-59.25%
Net Cash Per Share	0.04	0.01	0.03	0.01	0.20	0.21
Filing Date Shares Outstanding	412.74	402.15	351.25	181.38	178.1	157.89
Total Common Shares Outstanding	412.74	402.15	351.25	181.38	178.1	157.89
Working Capital	25.7	35.9	28	16.3	41.43	41.44
Book Value Per Share	0.15	0.11	0.17	0.27	0.41	0.40
Tangible Book Value	60.2	42.1	33.9	21.9	46.42	34.77
Tangible Book Value Per Share	0.15	0.10	0.10	0.12	0.26	0.22
Land	-	4.6	4.6	4.6	4.51	-
Machinery	-	4.3	6.8	6	5.11	3.78
Construction In Progress	-	0.1	0.1	1.4	0.15	0.03
Leasehold Improvements	-	2.3	2.6	0.9	0.74	0.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.